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Osteoporosis treatment always aimed at keeping the balance of bone formation and bone resorption. Recently, prenyl group in
natural products has been proposed as an active group to enhance the osteogenesis process. Osthole has both the prenyl group
and bone-protective activities, but the relationship is still unknown. In this study we found that osthole exerted a potent ability to
promote proliferation and osteogenic function of rat bone marrow stromal cells and osteoblasts, including improved cell viability,
alkaline phosphatase activity, enhanced secretion of collagen-I, bone morphogenetic protein-2, osteocalcin and osteopontin,
stimulated mRNA expression of insulin-like growth factor-1, runt-related transcription factor-2, osterix, OPG (osteoprotegerin),
RANKL (receptor activator for nuclear factor-𝜅B ligand), and the ratio of OPG/RANKL, as well as increasing the formation of
mineralized nodules. However, 7-methoxycoumarin had no obvious effects. Osthole also inhibited osteoclastic bone resorption to
a greater extent than 7-methoxycoumarin, as shown by a lower tartrate-resistant acid phosphatase activity and lower number and
smaller area of resorption pits. Our findings demonstrate that osthole could be a potential agent to stimulate bone formation and
inhibit bone resorption, and the prenyl group plays an important role in these bone-protective effects.
1. Introduction
Osteoporosis was first defined as a progressive systemic
skeletal disease characterized by low bone mass andmicroar-
chitectural deterioration of bone tissue, with a consequent
increase in bone fragility and susceptibility to fracture by the
World Health Organization (WHO) expert panel in 1994 [1].
Osteoporosis is one of the most common metabolic bone
diseases that often leads to osteoporotic fractures which are
a major source of morbidity and mortality in the ageing pop-
ulation and place a significant health and economic burden
on society [2]. Generally, osteoporosis is believed to be the
result of imbalanced bone remodeling with decreased bone
formation (carrying out by osteoblasts) and/or increased
bone resorption (carried out by osteoclasts). So in the last
decade, a series of new drugs have been developed to
improve the bone quality, based on the understanding of
the metabolism of the bone tissue, either by stimulating the
bone anabolic effects, suppressing the catabolic effects, or
together [3]. Although the present antiosteoporosis agents
have already obtained satisfactory effects, some therapeutic
drugs still possess some side effects, including the potential
incidences of osteonecrosis of the jaw bone caused by large
doses of bisphosphonates [4], osteosarcomas caused by high
doses of PTH [5], and increased risk of endometrial and
breast cancers due to prolonged use of hormone replacement
therapy (HRT) [6]. Novel drugs, which could prevent the
bone loss, have little adverse effects, and are cost-effective, are
desired.
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Figure 1: Chemical structures of 7-methoxycoumarin (a) and osthole (b).
In recent years, Chinese herbal medicine (CHM) has
attracted attention of many researchers because some of its
herbs, formulations, or extracts have osteoprotective effects,
low in cost, and have little or few side effects and thousands of
years history of usage in osteoporosis clinical practice. Some
of these herbs are Herba Epimedii [7], Cnidium monnieri (L.)
Cussion, RhizomaDrynariae, and Psoralea corylifolia. Among
these, the dried fruit of Cnidium monnieri (L.) Cussion, also
known as “Shechuangzi” in China and “Jashoshi” in Japan, is
one of the most frequently used classic remedy for treatment
of osteopenia and bone fractures [8].
Osthole (7-methoxy-8-isopentenoxy-coumarin, chemi-
cal structure shown in Figure 1), which is extracted from
Cnidium monnieri (L.) Cussion and is a natural coumarin
derivative, has been proved to possess many pharmacological
functions such as antioxidation [9], antitumor [10], anti-
inflammation [11], antidiabetes [12], and neuroprotective
effects [13]. Furthermore, accumulating evidence indicates
that osthole exhibits estrogen-like effects in ovariectomized
rats and can reduce bone loss and prevent osteoporosis [14].
Osthole, also a prenylation coumarin compound, was found
to have protective effect in the bone formation and bone
resorption studies. The effects of osthole on osteoblast pro-
liferation, differentiation [15], and osteoclast bone resorption
function [16] also were confirmed. In addition, the prenyl
group has been proposed as an active group to enhance
the osteogenesis process in recent years of some flavonoid
compounds, including genistein prenylated derivatives (6-
prenylgenistein, 8-prenylgenistein and 6,8-prenylgenistein)
which have been shown to better stimulate osteoblastic
proliferation, differentiation, andmineralization in UMR 106
cells than genistein itself [17]. However, whether the bone-
protective activity of osthole is related to the prenyl group
remains unknown. In the current study, through evaluating
the relationship between the osthole’s prenyl group and the
osteogenesis/osteoclastic resorption processes in vitro, we
sought to address our hypothesis that the prenyl group is
important for the osteoprotective property of osthole.
2. Materials and Methods
2.1. Animals and Reagents. Sprague-Dawley rats weighing
130–170 g were used for bone marrow stromal cell culture
studies, new born Sprague-Dawley rats for primary calvarial
osteoblast culture, and New Zealand white rabbits born
within 3 days were used for osteoclast culture, which all were
supplied by theAnimal Center of the FourthMilitaryMedical
University (Xi’an, China). All the procedures for cell isolation
from these rats and rabbits were carried out according to the
Guide for the Care and Use of Laboratory Animals, published
by the US National Institutes of Health, and approved
by Animal Ethics Committee of Fourth Military Medical
University.
7-methoxycoumarin (purity > 98%) was obtained from
Meryer Chemical Technology Company (Shanghai, China).
Osthole (purity > 99%) was purchased from Winherb Med-
ical Science Company (Shanghai, China). Culture media
(DMEM/F12 and 𝛼-MEM) and fetal bovine serum (FBS)
were purchased from HyClone (South Logan, Utah, USA).
Penicillin, streptomycin, and trypsin-EDTA Solution were
obtained from Gibco BRL (Gaithersburg, MD, USA).
Majority of other chemicals/reagents were purchased from
Sigma (Louis, MO, USA), including dexamethasone, 𝛽-
glycerophosphate, DMSO (dimethyl sulfoxide), 2-Phospho-




bromide), and Alizarin Red-S and acid phosphatase stain
kit. Kits for measuring alkaline phosphatase (ALP) activity
and tartrate-resistant acid phosphatase (TRAP) activity were
both purchased from Nanjing Jiancheng Company (Nanjing,
China). Enzyme linked immunosorbent assay (ELISA) kits
for the quantitative determination of osteocalcin, bone mor-
phogenetic protein-2 (BMP-2), and osteopontin (OPN) were
purchased from Cusabio Biotechnology (Wuhan, China),
while the collagen-I ELISA Kit from Sengxiong Biotech-
nology (Shanghai, China). RNAprep pure Cell Kit for total
RNA extraction, RNase-Free DNase I to remove any DNA
interference, Quantscipt RT Kit for cDNA preparation and
RealMasterMix (SYBR Green) for mRNA detection were
obtained from TIANGEN Biotechnology (Beijing, China)
and used according to the manufacturer’s instructions.
2.2. Isolation, Culture, and Treatments of Rat Bone Marrow
Stromal Cells (rBMSCs). Three normal Sprague-Dawleymale
rats weighing 130–170 g were killed by cervical dislocation.
Each animal’s femurs and tibias were dissected aseptically,
and after both ends of each bone were excised, bone marrow
was collected by flushing with DMEM/F12 culture medium
containing 100U/mL penicillin, 100 𝜇g/mL streptomycin and
10% FBS with a 22 gauge needle and a syringe. Single cell
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suspensions were prepared by gently mixing the cells with
a pipette followed by filtration through a 76𝜇m strainer
and then were cultured in 100-mm culture dishes (Nunc,
Denmark) at 8mL/dish, with an initial cell density of 5 ×
106 cells in 1mL medium. Culture medium was first removed
after 2 days, thereafter changed twice weekly until the cells
achieved 90% confluence. At that point, cells were collected
and subsequently cultured in the osteogenic medium (con-
taining 10−8M dexamethasone, 10mM 𝛽-glycerophosphate,
and 50 𝜇g/mL ascorbic acid phosphate) with or without 7-
methoxycoumarin and osthole (dissolved in DMSO with
final concentrations in culture media less than 0.05%). The
osteogenic culturemedia were refreshed every three days and
used for osteogenic differentiation assays.
2.3. Isolation, Culture, and Treatments of Rat Calvarial
Osteoblasts (ROB). ROBwere isolated from neonatal (<3 day
old) Sprague-Dawley rat calvarias by a sequential enzymatic
digestion method according to Bhat et al. [18] and Hino
et al. [19] with minor modifications. Briefly, eight calvariae
were excised aseptically, cleaned of soft tissues, and cut into
fragments (1mm× 1mm× 1mm).These bone fragmentswere
rinsed with PBS three times (each for 5min) and then treated
with 0.25% trypsin for 10min and then digested with enzyme
mixture (0.1% collagen II and 0.25% trypsin at a ratio 1 : 1) for
10min. The first and second supernatants were discarded in
order to diminish fibroblastic contamination and cell debris.
Then the bone fragments were digested four times with 0.1%
collagen II solution at 37∘C for 20min. Cells were obtained
by centrifugation at 250 g for 5min and cultured in 𝛼-
modified minimum essential medium (𝛼-MEM) containing
10% FBS and antibiotics (100U/mL penicillin and 100mg/mL
streptomycin). These cells were defined as passage 0; and by
80–90% confluence they were detached by treatment with
0.25% trypsin and 1mM EDTA and subcultured. Passage 2
cells were then seeded into 12-well plates for differentiation
or 96-well plates for proliferation assays.
2.4. Isolation, Culture, and Treatments of Rabbit Osteoclasts
(OC). Rabbit osteoclasts were isolated by a modified pro-
cedure from a previously described method [20]. Briefly,
long bones were dissected from four neonatal New Zealand
white rabbits (<3 day old) and were bisected longitudinally
with scissors. The inner wall of bones was scraped gently
with surgical knife and flushed by injecting culture medium
slowly using a sterile 25-gauge needle. Cell suspension was
harvested after filtering through a 76 𝜇m cell strainer. After
sedimentation for 1min, they were seeded into 24-well plates
at a density of 1 × 106 cells/well on sterile glass coverslips
for morphological examination or on bovine bone slices for
the bone resorption measurement. After an initial culture for
12 h, mediumwas changed and then the cells were cultured in





and antibiotic mixture for 9 days. The desired cultivated
cells were identified as osteoclasts based on their charac-
teristic appearance under microscopy and TRAP staining.
Osteoclasts also were stained with nuclear fluorescent dyes,
including hoechst 33342 (Beyotime, Haimen, China) and
acridine orange (Sigma, Louis, MO, USA).
2.5. Proliferation Assays with rBMSCs and ROB. The prolif-
eration of rBMSCs and ROB was determined by the MTT
assay, which measures reduction of 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide to a purple formazan
product [21]. Passage 1 rBMSCs or passage 2 ROB was
seeded at a density of 2 × 103 cells/well in 96-well plates
and cultured in DMEM/F12 or 𝛼-MEM supplemented with
3% FBS and 7-methoxycoumarin or osthole at different con-
centrations from 10−8 to 10−4M. After 48 h, culture medium
was discarded and cultures were rinsed twice with deionized
water, and then 50𝜇LMTT solution (0.5mg/mL) was added.
After incubation for 4 h, formazan crystals formed were
dissolved inDMSOand the absorbance valuewas determined
at 490 nm immediately. The effects of treatments on cell
viability were expressed as ratio of Absorbance of treated
cells/Absorbance of control cells [18].
2.6. Alkaline Phosphatase (ALP) Activity of rBMSCs and ROB.
ALP activity on the 9th day after osteogenic induction culture
wasmeasured by using a colorimetric endpoint assaymethod
[22]. Total cellular ALP activity was measured using an ALP
activity assay kit and was expressed as absorbance value at
520 nm.
2.7. Expression of Osteogenesis-Related Genes in rBMSCs and
ROB. rBMSCs and ROB were harvested and lysed at 0 h, 6 h,
12 h, 24 h, and 48 h after the osteogenic induction culture and
were subjected to qRT-PCR analyses to evaluate the effects
of 7-methoxycoumarin and osthole on mRNA expression of
the osteogenesis-related genes, including insulin-like growth
factor-1 (IGF-1), Osterix, Runx-2, OPG, and RANKL, with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an
internal control following the protocol described previously
[23]. Total RNA was extracted by using RNAprep pure
Cell Kit and treated with DNase I to remove any DNA
contamination. The concentration and purity of total RNA
were determined by absorbance at 260/280 nm in a UV
spectrophotometer, and the integrity was checked by 1.5%
agarose gel electrophoresis. Complementary DNA (cDNA)
was synthesized by using Quantscipt RT Kit in 20𝜇L reac-
tions containing 1 𝜇g total RNA. qRT-PCR reaction was
carried out in iQ5 PCR system (Bio-Rad, USA) by using
RealMasterMix PCR Kit. Primers were designed with the
Primer Express 3.0 software based on published rat cDNA
sequences in NCBI and the sequences were listed in Table 1.
2.8. Secreted Levels of Osteocalcin, BMP-2, OPN, Collagen-I in
rBMSCs, and ROB. The levels of osteocalcin, BMP-2, OPN,
and collagen-I proteins produced by rBMSCs and ROB in the
culture medium were determined by the ELISA Kits accord-
ing to the manufacturer’s instructions. Absorbance values
at 450 nm of samples and standards at serial concentrations
were obtained by Synergy HTMonochromator-based Multi-
Mode Microplate Reader (Bio-Tek, Winooski, VT, USA) and
translated into the concentrations of these proteins. Final
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Table 1: Primer sequences used for qRT-PCR.
Gene Gene bank number Primer sequence Product length (bp)
IGF-1 NM 001082477.2 Forward 5
󸀠-TTCAGTTCGTGTGTGGACCAAG-3󸀠 120Reverse 5󸀠-GATCACAGCTCCGGAAGCAA-3󸀠
Runx-2 NM 053470.2 Forward 5
󸀠-GCACCCAGCCCATAATAGA-3󸀠 165Reverse 5󸀠-TTGGAGCAAGGAGAACCC-3󸀠
Osterix NM 001037632.1 Forward 5
󸀠-GCCTACTTACCCGTCTGACTTT-3󸀠 131Reverse 5󸀠-GCCCACTATTGCCAACTGC-3󸀠
OPG NM 012870.2 Forward 5
󸀠-TCCTGGCACCTACCTAAA-3󸀠 110Reverse 5󸀠-ACACGCATTCATCACTCG-3󸀠
RANKL NM 057149.1 Forward 5
󸀠-CATCGGGTTCCCATAAAG-3󸀠 140Reverse 5󸀠-GAAGCAAATGTTGGCGTA-3󸀠
GAPDH NM 017008.3 Forward 5
󸀠-TATCGGACGCCTGGTTAC-3󸀠 140Reverse 5󸀠-CTGTGCCGTTGAACTTGC-3󸀠
results were expressed as ng/mL culture medium during 0–
3 d, 3–6 d, 6–9 d, and 9–12 d culture periods, respectively.
2.9. Measurements of the Calcified Nodules Formed from
rBMSCs and ROB. Calcified nodules formed at 12th day were
analyzed by Alizarin Red-S staining and quantification. After
rBMSCs or ROB was cultured in osteogenic medium for
12 d, cells were fixed in 4% paraformaldehyde for 10min and
subsequently washed three times with deionized water. Then
the cells were stained with 0.1% Alizarin Red-S in Tris-HCl
buffer (pH 8.32) for 1 h at 37∘C. The stained culture plates
were photographed and the areas and relative intensities of
calcified nodules were quantified by using Image-Pro plus 6.0
software.
2.10. TRAP Staining and Activity Assay of Osteoclasts. TRAP
staining of rabbit osteoclasts at 6th day of osteoclastic culture
were carried using aTRAP staining kit. All theTRAP-positive
cells containing three or more nuclei cells were defined as
osteoclasts under a light microscope. In addition, the TRAP
activity of rabbit osteoclasts at 6th day of culture was also
determined by colorimetric endpoint assay using a TRAP
measurement Kit and expressed as the absorbance value at
530 nm.
2.11.Measurement of the BoneResorptionAbility ofOsteoclasts.
Rabbit osteoclasts were isolated and plated on the bovine
bone slices (6 × 6mm square slices of 150–200𝜇m thick)
and then resorption pits at 9th day of culture were examined
to investigate treatment effects on bone resorptive ability.
Slices were fixed by 2.5% glutaraldehyde solution for 10min
and washed with 0.25M ammonia solution for 5min for 3
times. Then the slices were dehydrated in graded alcohols
and stained with 1% toluidine blue solution for 10min. After
washwith deionizedwater, the resorption pits were visualized
under light microscopy. Areas and relative intensities of
resorption pits were analyzed using Image-Pro plus 6.0
software.
2.12. Statistical Analysis. The data in MTT and ALP activity
assays were from six parallel replicates (𝑛 = 6) and other
examinations from three replicates (𝑛 = 3). Each experiment
was repeated 3 times. All data were presented as mean ±
standard deviation (SD) and analyzed using one-way
ANOVA followed by the LSD post hoc test using SPSS 17.0
software (Chicago, IL, USA). The statistically significant
difference was considered at the level of 𝑃 values < 0.05.
3. Results
3.1. Cell Morphological Observation of Cultured rBMSCs, ROB
and OC. rBMSCs in the primary culture were adherent to
the bottom of culture plate after 24 h culture and appeared
irregular in shape (Figure 2(a)); and at the first medium
change, the adherent cells were spindle-like or polygon-
like (Figure 2(b)). After culture for 8 d in osteogenic media,
mineral salts were seen extracellularly and the outlines of
rBMSCs were not very clear (Figure 2(c)). Matured calcified
nodules had formed after culture for 12 d in osteogenic media
and appeared light brown before the staining (Figure 2(d))
and dark red after Alizarin Red-S staining (Figure 2(e)).
Primary ROB were mostly seen attached to the culture
plate and appeared fusiform, triangle or irregular at 24 h
after seeding (Figure 2(f)). Passage 2 ROB was larger in size
than primary ROB and appeared uniform and slabstone-
like (Figure 2(g)). After 8 d culture in osteogenic medium,
passage 2 ROB secreted calcium salts and formed calcified
nodules (Figure 2(h)). At 12th day, mature mineralized nod-
ules appeared dark brown before theAlizarin Red-S stainning
(Figure 2(i)) and dark red after the staining (Figure 2(j)).
Rabbit osteoclasts isolated from neonatal New Zealand
white rabbits were irregular in shape,multinuclear, and larger
in size than rBMSCs and ROB (Figure 2(k)). One of the most
important characters of OC is the multinuclear nature, as
shown in Figure 2(l) after being stained by hoechst 33342.
Themerged image (Figure 2(m)) of the osteoclast profiles and
their nuclei showed clear locations of multiple nuclei within
the osteoclasts. Multinuclear osteoclasts were also displayed
in Figure 2(n) after being stained by acridine orange. Another
important feature of osteoclasts is the positive TRAP-staining
in the cytoplasm (Figure 2(o)).
3.2. Effects on Cell Viability of rBMSCs and ROB. Treatment
effects on the viability (cell growth and survival) of rBMSCs
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Figure 2: Morphology of cultured rat bone marrow stromal cells (rBMSCs), rat calverial osteoblasts (ROB), and rabbit osteoclasts (OC).
Appearances of rBMSCs after being cultured for 24 h (a), after the first medium change (b), after being cultured for 8 d in osteogenic media
with secreted mineral salts (c), after being cultured for 12 d showing presence of mature calcified nodules formed (d), and appearing dark
red after Alizarin Red-S staining (e). Appearance of primary ROB after being seeded for 24 h (f); passage 2 cells appearing uniform and
slabstone-like after being cultured in osteogenic medium 4 d (g); presence of calcified nodules after 8 d of osteogenic induction culture (h);
presence of mature mineralized nodules after osteogenic induction culture 12 d (i), and appearing dark red after the Alizarin Red-S staining
(j). Isolated rabbit primary osteoclasts displayed irregular shape, multinuclear, and large size (k); nuclei of osteoclasts as stained with hoechst
33342 dye (l) and the merged image (m). Multinuclear appearance of osteoclasts as displayed by acridine orange staining (n); and osteoclasts
as TRAP-stained positive multinuclear cells (o). (a)–(j) were observed under the phase contrast microscopy (Olympus, 100x) and (k)–(o)
were observed under Eclipse 80i Fluorescence Microscope (Nikon, 100x).
and ROB were determined by MTT assay (Figure 3). After
48 h culture with the 7-methoxycoumarin and osthole at a
range of concentrations (from 10−8 to 10−4M), there was a
significant increase in the rBMSCs viability (expressed as a
ratio over the untreated control group) in the presence of
osthole at a concentration range from 10−7 to 5 × 10−6Mwith
a dose-dependent manner (𝑃 < 0.05 or 𝑃 < 0.01 versus
control). While the viability of rBMSCs in osthole group
declined from 10−5 to 10−4M, the viability at 10−5M and 5
× 10−5M was still higher than the control group. Although
the rBMSCs viability in 7-methoxycoumarin-treated groups
increased slightly at the concentration range from 10−7 to 5 ×
10−6M, the changes were not statistically significant.The via-
bility in 7-methoxycoumarin-treated rBMSCs also decreased
significantly at 5 × 10−5M and 10−4M concentrations when
compared with the control group (Figure 3(a)).
Osthole can stimulate the proliferation and survival of
ROB as ROB viability increased in the presence of osthole at
the concentration range from 10−7 to 5 × 10−5M (𝑃 < 0.05
or 𝑃 < 0.01 versus control), although the viability at 10−4M
was almost close to the control group. ROB viability in 7-
methoxycoumarin groups was similar to the control except
at the 10−4M concentration at which it decreased notably
(𝑃 < 0.05) when compared with control (Figure 3(b)).
3.3. Effects on ALP Activity of rBMSCs and ROB. ALP
activity, which indicates the osteogenic differentiation of
rBMSCs and the maturation of ROB directly, was measured
as a marker for screening the optimal concentration(s) of
7-methoxycoumarin and osthole in promoting osteogenic
differentiation/maturation in vitro. As shown in Figure 4,
ALP activity was increased in the presence of osthole at
concentrations of 10−8M to 10−5M, especial at 10−7M to
10−5M in rBMSCs and 5 × 10−7M to 10−5M in ROB (𝑃 <
0.05 or 𝑃 < 0.01 versus control). ALP activity in osthole-
treated cells peaked at 10−5M and then declined with the
increasing concentration until 10−4M at which the ALP was
near to the control; this tendency was observed both in
rBMSCs and ROB culture systems. However, after treatments
with different concentrations of 7-methoxycoumarin, there
were no significant changes in ALP activity in both rBMSCs
and ROB, except for a decrease at 10−4M in ROB when
compared with control group (𝑃 < 0.05). The above dose-
dependent studies revealed that the optimal concentrations
of osthole in rBMSCs and ROB were at 10−5M and that 7-
methoxycoumarin had no significant positive effects on the
ALP activity in both rBMSCs and ROB. Thus osthole and 7-
methoxycoumarin were used in subsequent experiments at
the concentrations of 10−5M.
3.4. Effects on the mRNA Expression of Osteogenesis-Related
Genes during Osteogenic Culture of rBMSCs and ROB.
Expression of osteogenesis-related genes in rBMSCs and
ROB was examined after different durations of osteogenic

























































































































































Figure 3: Dose-dependent effects of 7-methoxycoumarin (a) and osthole (b) on the viability of rat bone marrow stromal cells (rBMSCs) and
rat calverial osteoblasts (ROB). The cells were grown and treated with culture medium containing 3% FBS and indicated concentrations of
7-methoxycoumarin and osthole. The cell viability of rBMSCs and ROB were measured by MTT assay for 48 h. The data represented three
experiments and were shown as the mean ± SD of sextuplicate wells. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 represent significant differences between the




































































































































































Figure 4: Dose-dependent effects of 7-methoxycoumarin (a) and osthole (b) on alkaline phosphatase (ALP) activity in rat bone marrow
stromal cells (rBMSCs) and rat calverail osteoblasts (ROB). rBMSCs and ROBwere cultured in osteogenic culture medium and supplied with
different doses of 7-methoxycoumarin and osthole. Data were represented by three experiments and shown as the mean ± SD of sextuplicate
wells. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 represent significant differences between the drug-supplemented groups and the control.
induction culture supplemented with 7-methoxycoumarin or
osthole, including IGF-1, Runx-2,Osterix,OPG, andRANKL.
IGF-1 was synthesized in the liver and enhanced the differ-
entiated function of the osteoblast and bone formation [24].
In vitro and in vivo studies have shown that IGF-1 enhances
matrix apposition and decreases collagen degradation [25].
As shown in Figures 5(a) and 6(a), the mRNA expression of
IGF-1 increased quickly at 6 h after osteogenic induction cul-
ture in rBMSCs and ROB, peaked at 24 h, and then declined
gradually. This tendency was maintained among the control,
7-methoxycoumarin, and osthole-treated groups; however,
the osthole-supplemented group always produced the highest
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Figure 5: Time-course changes inmRNA levels of osteogenesis-related genes in rat bonemarrow stromal cells (rBMSCs) at 6 h, 12 h, 24 h, 36 h,
or 48 h after osteogenic culture treated with 10−5M7-methoxycoumarin or osthole or neither (control). Levels of expression were determined
by qRT-PCR and are presented as fold changes relative to the control after being standardized against internal control GAPDH. (a) IGF-1; (b)
Runx-2; (c) Osterix; (d) OPG; (e) RANKL; (f) OPG/RANKL. Results are expressed as the mean ± SD, ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus control;
#
𝑃 < 0.05, ##𝑃 < 0.01 versus 7-methoxycoumarin.





































































































































































































Figure 6: Time-course changes in mRNA levels of osteogenesis-related genes in rat calverial osteoblasts (ROB) at 6 h, 12 h, 24 h, 36 h, or 48 h
after osteogenic culture treated with 10−5M 7-methoxycoumarin or osthole or neither (control). Levels of expression were determined by
qRT-PCR and are presented as fold changes relative to the control after being standardized against internal control GAPDH. (a) IGF-1; (b)
Runx-2; (c) Osterix; (d) OPG; (e) RANKL; (f) OPG/RANKL. Results are expressed as the mean ± SD, ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus control;
#
𝑃 < 0.05, ##𝑃 < 0.01 versus 7-methoxycoumarin.
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Figure 7: Time-course changes in the secretion of osteogenesis-related proteins after different days of osteogenic induction culture of rat bone
marrow stromal cells (rBMSCs) treatedwith 10−5M7-methoxycoumarin or osthole or neither (control). Protein levels in conditionedmedium
were determined by ELISA assays for collagen-I (a), BMP-2 (b), osteocalcin (c), and OPN (d). Results were represented by three experiments
and shown as the mean ± SD of triplicate wells. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus control; #𝑃 < 0.05, ##𝑃 < 0.01 versus 7-methoxycoumarin.
IGF-1 mRNA level among these three groups. Although the
IGF-1 mRNA levels in 7-methoxycoumarin group appeared
higher than control, the differences were not statistically
significant. Furthermore, the osthole group also displayed
higher IGF-1 mRNA levels than 7-methoxycoumarin group,
especially at 6 h and 24 h in rBMSCs (𝑃 < 0.05) and at 24 h
and 48 h in ROB (𝑃 < 0.05).
Runx-2, also known as core binding factor 𝛼-1 (Cbf𝛼-1),
was thought to be the initial critical osteogenic transcription
factor required for the differentiation of mesenchymal
cells into preosteoblasts [26]. qRT-PCR analysis revealed
that Runx-2 mRNA expression had different patterns
between rBMSCs and ROB. Runx-2 levels increased with
the osteogenic culture, peaked at 12 h in rBMSCs and 24 h in
ROB, and then declined gradually afterwards (Figures 5(b)
and 6(b)). However, Runx-2 mRNA levels in osthole group
always were highest among the 3 groups in all time points
examined, and in both rBMSCs and in ROB.
Osterix, an osteogenic transcription factor downstreamof
Runx-2, is required for the differentiation of preosteoblasts
into mature osteoblasts [27]. In rBMSCs (Figure 5(c)), ost-
hole induced a peak level of osterix after 24 h osteogenic
culture andmaintained a similar level at 36 h; then the osterix
level decreased at 48 h. However, osterix mRNA levels in 7-
methoxycoumarin and control declined slightly from 24 h to
48 h in rBMSCs andwere not significantly differently between
these two groups. In ROB (Figure 6(c)), levels of osterix
mRNA increased and decreased synchronically in all three
groups, which all peaked at 24 h. Similar with the results in
rBMSCs, the osthole group still induced the highest osterix
mRNA levels in ROB at all time points when compared with
7-methoxycoumarin and control groups (𝑃 < 0.05 or 𝑃 <
0.01).
10 International Journal of Endocrinology


































































































































































Figure 8: Time-course changes in the secretion of osteogenesis-related proteins after different days of osteogenic induction culture of rat
calverial osteoblasts (ROB) treated with 10−5M 7-methoxycoumarin or osthole or neither (control). Protein levels in conditioned medium
were determined by ELISA assays for collagen-I (a), BMP-2 (b), osteocalcin (c), and OPN (d). The results were represented by three
experiments and shown as the mean ± SD of triplicate wells. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus control; #𝑃 < 0.05, ##𝑃 < 0.01 versus 7-
methoxycoumarin.
OPG and RANKL are two proteins secreted by osteo-
blasts, which critically regulate osteoclast differentiation.
While RANKL stimulates the differentiation of osteoclast
precursor cells into mature osteoclasts, the OPG acts as
antagonist through binding to RANKL and thus inhibits
osteoclastogenesis process [28]. Osthole considerably pro-
moted expression of OPG, with its effect peaking at 36 h
after the osteogenic culture and then declining slowly in
both rBMSCs (Figure 5(d)) and ROB (Figure 6(d)). Further-
more, osthole group produced 6 times and 3 times more
OPG than the initiation point in ROB and rBMSCs at its
peak point, respectively. In contrast, RANKL mRNA levels
gradually decreased with the osteogenic induction culture
of rBMSCs (Figure 5(e)) and ROB (Figure 6(e)). Osthole
decreased the RANKL mRNA expression most notably
among the three groups in either rBMSCs or ROB culture,
especially at 6 h and 36 h in rBMSCswhen comparedwith the
7-methoxycoumarin group, although the differences between
these two groups in ROB were not statistically different.
Since bone remodeling potential can also be assessed by
the relative ratio of OPG to RANKL, with higher ratio values
indicating stronger bone protective effects [29], effects of ost-
hole or 7-methoxycoumarin treatments onOPG and RANKL
expression in rBMSCs and ROB cultures were also expressed
as OPG/RANKL ratio.With the osteogenic induction culture
in both rBMSCs (Figure 5(f)) and ROB (Figure 6(f)), the
ratio of OPG/RANKL increased rapidly. In rBMSCs culture,
the OPG/RANKL ratios of osthole group were significantly
higher than the control group from 6 h to 48 h and than the
7-methoxycoumarin group from 24 h to 48 h (𝑃 < 0.05 or
𝑃 < 0.01). In ROB culture, the ratios were higher in osthole
group than the control and the 7-methoxycoumarin groups
at all time points except 24 h (𝑃 < 0.05 or 𝑃 < 0.01).



















































































Figure 9: Effects of treatment with 10−5M 7-methoxycoumarin or osthole or neither (control) on calcified nodules formation in rat bone
marrow stromal cells (rBMSCs). Alizarin Red-S stained calcified nodules formed at 12th day after osteogenic induction culture (a). Number
(b), total area (c), and staining intensity (integrated optical density or IOD) (d) of mineralized nodules were measured by Image-Pro Plus 6.0
software. The results are shown as the mean ± SD of triplicate cultures. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus control; #𝑃 < 0.05, ##𝑃 < 0.01 versus
7-methoxycoumarin.
3.5. Effects on the Secretion of Osteogenesis-Related Proteins in
rBMSCs and ROB. Type-I collagen is themain component of
bonematrix and its degradation always causes bone loss [30].
With osteogenic induction culture, collagen-I secretion (as
indicated by the levels in the conditionedmedium) increased
gradually in both rBMSCs and ROB cultures, and the levels
of collagen-I declined at 9–12 d time point. During the whole
time course, the osthole group always induced the highest
concentrations of collagen-I among these three groups. At all
time points of the osteogenic culture of rBMSCs (Figure 7(a))
and ROB (Figure 8(a)), collagen-I concentrations in the
osthole group were significantly higher than the other two
groups (𝑃 < 0.05 or𝑃 < 0.01), while therewere no differences
between 7-methoxycoumarin and control groups.
BMP-2 [31] is known to induce mesenchymal cells to
differentiate into osteogenic cells, and osteocalcin [32] and
OPN [33], often used as the biochemical markers for bone
formation, are known also to play important roles in the dif-
ferentiation process of osteoblasts. As shown in Figures 7(b)–
7(d) and Figures 8(b)–8(d), trends of changes of conditioned
medium levels during the osteogenic culture time course are
similar for BMP-2, osteocalcin, and OPN in both rBMSCs
and ROB. The secretion of these proteins increased persis-
tently with a time-dependent manner in both rBMSCs and
ROB cultures. At the early stage (0–3 d), there were no signif-
icant differences in the protein concentrations among these
three groups, except that osteocalcin level was higher than the
control in rBMSCs (𝑃 < 0.05) andOPN level was higher than
the control in ROB (𝑃 < 0.05). The secretion levels of these
proteins of the osthole group were consistently higher (𝑃 <
0.05 or 𝑃 < 0.01) than the other two groups during 3–12 d of
osteogenic culture in both rBMSCs and ROB, with the only
exception of the OPN secretion during 9–12 d in rBMSCs
culture. The levels of these proteins in 7-methoxycoumarin
group were not statistically different from the control levels
in every time points in both rBMSCs and ROB.
3.6. Effect on Mineralization Potential in rBMSCs and ROB.
To investigate the treatment effects on the mineralization












































































Figure 10: Effects of treatment with 10−5M7-methoxycoumarin or osthole or neither (control) on calcified nodules formation in rat calverial
osteoblasts (ROB). Alizarin Red-S stained calcified nodules formed at 12th day after osteogenic induction culture (a). Number (b), total area
(c), and staining intensity (integrated optical density or IOD) (d) of calcified nodules were measured by Image-Pro Plus 6.0 software. Results
are shown as the mean ± SD of triplicate cultures. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus control; #𝑃 < 0.05, ##𝑃 < 0.01 versus 7-methoxycoumarin.
potential of rBMSCs and ROB, calcified nodules formedwere
analyzed by staining of Alizarin Red-S at 12th day after the
osteogenic culture.Among the three groups, calcifiednodules
in osthole group appeared larger in size, darker in staining,
and more in number than the other two groups (Figures
9(a) and 10(a)), and the quantified data showed that osthole-
treated group produced the highest number (Figures 9(b)
and 10(b)), largest area (Figures 9(c) and 10(c)) and highest
IOD (integrated optical density) staining value (Figures 9(d)
and 10(d)) of mineralized nodules in both rBMSCs and ROB
(𝑃 < 0.05 or 𝑃 < 0.01 versus control groups), confirming the
stimulatory effect of osthole in the osteogenic differentiation
and mineralization. However, 7-methoxycoumarin did not
enhance the formation of calcified nodules both in rBMSCs
and ROB (𝑃 > 0.05 versus controls for all the three
measurements).
3.7. Effects onTRAPActivity andBone Resorption in the Rabbit
Osteoclasts. TRAP was one of the most important markers
of the osteoclasts and was essential for osteoclast migration
and bone resorption [34]. To assess treatment effects on
osteoclast activity, TRAP activity was measured at 6th day of
osteoclast culture. As shown in Figure 11, osthole treatment
decreased the TRAP activity notably when compared with
7-methoxycoumarin group (𝑃 < 0.05) or with the control
group (𝑃 < 0.01). Although 7-methoxycoumarin also had
a trend of reducing the TRAP activity when compared with
control, the difference did not reach statistical significance
(𝑃 > 0.05). Consistent with the effects on TRAP activity were
the effects on bone resorption activity of osteoclasts at 9th day
as evaluated by the numbers, areas, and the IOD of stained
pits formed by osteoclasts (Figure 12(a)). The number of pits
in osthole groupwas lower than those in 7-methoxycoumarin























Figure 11: Effects of treatment with 10−5M 7-methoxycoumarin or
osthole or neither (control) on TRAP activity in cultured rabbit





TRAP activity was expressed as the absorbance value at 530 nm.
Data were shown as mean ± SD of triplicate cultures. ∗𝑃 < 0.05,
∗∗
𝑃 < 0.01 versus control; #𝑃 < 0.05, ##𝑃 < 0.01 versus 7-
methoxycoumarin.
(𝑃 < 0.05) and control groups (𝑃 < 0.01) (Figure 12(b)). The
osthole treatment effects on the total area and IOD of pits had
the same tendency as the effects on pit numbers (𝑃 < 0.05
or 𝑃 < 0.01) (Figures 12(c) and 12(d)). 7-methoxycoumarin
group also had a lower number, a smaller area and IOD of
pits than the control group (𝑃 < 0.05 or 𝑃 < 0.01) (Figures
12(b)–12(d)).
4. Discussion
Osteoporosis is now widely recognized to be caused by the
imbalance of bone formation and bone resorption, which
increases fracture risk [35]. Because of the side effects of
HRT, there has been an increasing interest in looking for
alternative osteoporosis treatments to the classical HRT, such
as dietary estrogenic compounds (phytoestrogens) which
have shown some potential benefits for osteoporosis therapy
[36] and have attracted many researchers’ attention [37].
Phytoestrogens comprise a set of secondary plantmetabolites
belonging to the chemical classes of coumestans, isoflavones,
flavanones, and lignans, which all could activate the human
estrogen receptor [38]. Recent studies on structure-function
relationships have shown that the prenyl group may increase
the estrogenic activity, even though the final activity may
also depend on the position of prenyl group and the basic
structure of the compound [39]. Osthole, also possessing a
prenyl group, was considered to be able to prevent bone loss
through an estrogen-like effect in a rat osteoporosis model
study [40]. It also was shown that osthole stimulated the
proliferation of osteoblast-like UMR106 cells in vitro [41].
However, it has been unclear how osthole exerts its potential
osteoprotective effects and it has been unknown whether the
prenyl group is important for the bone protective property
of osthole. The current study now has also demonstrated the
important role of the prenyl group in osteoprotective action
of osthole in promoting osteogenesis and in suppressing
osteoclastic resorption.
The current study compared the activities of osthole and
7-methoxycoumarin (differing in structure only with the lack
of the prenyl group, Figure 1) in modulating the osteogenic
differentiation and mineralizing function (from rat rBMSCs
and osteoblasts) and formation and bone resorptive functions
of rabbit osteoclasts in vitro. Osthole was found to stim-
ulate rBMSCs and osteoblast proliferation, differentiation,
maturation and mineralization, while 7-methoxycoumarin
had no effects. In the present study, osthole was found
to significantly improve the cell viability and ALP activity,
enhance the secretion of collagen-I, BMP-2, osteocalcin, and
OPN, stimulate the gene expression of IGF-1, Runx-2, osterix,
OPG, and RANKL, and increase the number and area of
mineralized nodules formed. These data strongly indicate
that osthole promotes the proliferation, differentiation, and
osteogenic function of rBMSCs and osteoblasts and that
7-methoxycoumarin was not shown to be osteogenic in
comparison.
In addition, osthole was found to be more potent than
7-methoxycoumarin in raising the OPG/RANKL ratio in
cultured rat rBMSCs and osteoblasts, which is known as
an index for anti-resorption activity. Consistently, while 7-
methoxycoumarin and osthole were both found to inhibit
the osteoclast formation and bone resorption activity in
vitro, osthole was found to inhibit osteoclast formation
and bone resorption activity to a greater degree than 7-
methoxycoumarin, as revealed by a lower TRAP activity, a
lower number and a smaller area of bone resorption pits
formed.
We analyzed structure-function relationships and found
that the only difference in the chemical structure between 7-
methoxycoumarin and osthole is the presence of the 8-prenyl
group in osthole but not in 7-methoxycoumarin (Figure 1);
thus any differences in stimulating osteogenic or inhibiting
osteoclastic activities between the two molecules can be
attributed to the 8-prenyl group. Because of this, our findings
of the far greater ability of osthole than 7-methoxycoumarin
in promoting osteogenic differentiation and function and
inhibiting osteoclastic resorption indicated that 8-prenyl
group plays an important role in the osteoprotective activity
of osthole. Consistentwith our argument, recently,Ming et al.
compared the activities of 8-prenylnaringenin (PNG) and
naringenin (NG) in osteoblast and osteoclast differentiation
and their functions and showed that the 8-prenyl group
played an important role in promoting osteogenesis and
suppressing osteoclastogenesis and contributed to the higher
bone-protective activity of PNG in comparisonwithNG [42].
Themolecular mechanisms of the bone-protective action
of osthole are still not very clear. Only two studies were
found so far which related to the action mechanisms of
osthole. Tang et al. [43] found that local injection of osthole
significantly increased new bone formation on the surface of
mouse calvaria and prevented bone loss in ovariectomized
rats. They also showed that targeted deletion of the 𝛽-catenin
and Bmp2 genes could abolished the stimulatory effects of








































































Figure 12: Effects of treatment with 10−5M 7-methoxycoumarin or osthole or neither (control) on bone resorption pits formed by rabbit
osteoclasts at the 9th day. Bone resorption pits were stained by toluidine blue (a). Number (b), total area (c), and intensity of staining
(integrated optical density or IOD) (d) of bone resorption pits were measured by Image-Pro Plus 6.0 software. Data were shown as mean
± SD of triplicate cultures. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 versus control; #𝑃 < 0.05, ##𝑃 < 0.01 versus 7-methoxycoumarin.
osthole on osteoblast differentiation in vitro, suggesting that
the stimulating effect of osthole in osteoblast differentiation
may be through the activation of Wnt/𝛽-catenin-BMP-2
signaling pathway. Kuo and colleagues [44] showed that
osthole induces maturation and differentiation in MG-63
and hFBO cells, two human osteoblast-like cell lines. They
also observed that, for osthole-mediated differentiation of
osteoblast cells, BMP-2/p38 pathway activation is required for
the early phase of differentiation, whereas ERK1/2 pathway
activation is associated with the later phase.These two studies
above indicated that the osteogenic effect of osthole involves
the production of BMP-2 and may be mediated by multiple
pathways and potential pathway cross-talk. Consistently, our
current work also showed that osthole treatment can also
strongly induced the two major osteogenic growth factors,
BMP-2 and IGF-1 [24], in both rBMSCs and rat osteoblasts.
Furthermore, we showed that osthole can strongly modulate
production of OPG and RANKL (increasing OPG/RANKL
ratio) in osteoblasts and consistently osthole was shown
to potently inhibit osteoclastic resorptive function. Thus,
together, data from the previous studies and our current
study have now improved our mechanistic understanding
for the action mechanisms of osthole in its osteoprotective
(proosteogenic and antiresorptive) effects.
In summary, the present in vitro study proved that
prenyl group mediates the beneficial effects of osthole and
contributes to the higher osteoprotective activity of osthole
in comparison with 7-methoxycoumarin. Although further
studies are needed to explainwhy osthole could increase bone
formation and decrease bone resorption, we at least have
proved that its prenyl group plays an important role in these
osteotrophic activities. While the current study and previous
study [42] indicate that the addition of a prenyl group may
enhance the bone-protective activity of some phytoestrogens,
International Journal of Endocrinology 15
further studies are still needed to confirm this and to study the
action mechanisms of the prenylated compounds.
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